Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2
Make sure patients understand exactly what off-label use means, what risks and benefits there are, and what the alternatives look like
As a research tool for investigating fundamental questions about tissue homeostasis, aging mechanisms, and regenerative capacity, the GLOW Blend provides investigators with unprecedented ability to study the integrated biological networks underlying tissue repair while maintaining the experimental control afforded by well-characterized individual components
Preclinical research indicates it exerts cytoprotective effects across multiple organ systems, promotes angiogenesis, modulates nitric oxide pathways, and interacts with growth-factor systems involved in tissue repair [1] [2]